A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
Authors:
Open Access
- 8 August 2022
- journal article
- research article
- Published by Elsevier in Neurotherapeutics
- Vol. 19 (5) , 1588-1602
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet
- Petrus och Augusta Hedlunds Stiftelse
- Åke Wiberg Stiftelse
- Åhlén-stiftelsen
- Jeanssons Stiftelser
- Magnus Bergvalls Stiftelse
- VINNOVA
- Alzheimerfonden
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Hjärnfonden
- Gun och Bertil Stohnes Stiftelse
- Uppsala University
This publication has 62 references indexed in Scilit:
- Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samplesActa Neuropathologica, 2013
- Pharmacokinetics and Brain Uptake of a Genetically Engineered Bifunctional Fusion Antibody Targeting the Mouse Transferrin ReceptorMolecular Pharmaceutics, 2009
- Amyloid‐β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic miceThe FEBS Journal, 2009
- Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouseBiotechnology and Bioengineering, 2008
- Sensitive ELISA detection of amyloid‐β protofibrils in biological samplesJournal of Neurochemistry, 2007
- The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic miceNeurobiology of Aging, 2006
- Structural properties of Aβ protofibrils stabilized by a small moleculeProceedings of the National Academy of Sciences, 2005
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- Distances between the antigen-binding sites of three murine antibody subclasses measured using neutron and x-ray scatteringBiochemistry, 1992